A Quarterly Publication of City of Hope | Volume 18 Number 3 | Summer 2007


FOX Sports scores against cancer with City of Hope

NFL players and commentators to promote mission and appeal for support.

Keep reading

Building on achievement

Scientists make predecessors’ discoveries count.

Keep reading

Biller Center blends science with caring

Patients, family members find tools to empower themselves before, during and after treatment.

Keep reading

Pair of chairs boost leadership

Endowments back compassionate care, gene therapy.

Keep reading



Solace in the rose garden

Sherri Gilmour found faith and hope among flowers.

Keep reading

Research & Treatment

Immunity mutiny

Scientists want to rewrite the drama within a transplant patient’s immune system.

Buried evidence

Telltale DNA clues show personal risks of secondhand smoke.

Gut check

Researchers find Asian-Americans hold survival advantages in certain cancers.

The energy behind cancer

A new tool may help pull the plug on tumor cells.


Survivor gives back to fight cancer

From personal experience, Richard and Selma Ehrlich understand the urgency of City of Hope’s mission. Not only has the couple lost friends and family to cancer, but Richard Ehrlich himself is a survivor of the disease. Keep reading

Dedicated couple leave legacy of caring

Few people are as tireless in their devotion to philanthropy as Max and Shirley Newman were. “Max and Shirley did absolutely everything for City of Hope,” said longtime friend Don Hoffman, “They really went above and beyond.” Keep reading

Bequests create lasting legacy of hope and healing

Because many bequests are unrestricted gifts, they have particular power to help in the fight against cancer and other life-threatening diseases. Unrestricted gifts allow City of Hope the flexibility to direct funds where they can make the most impact. Keep reading

Grants at a Glance

Recent major grants support studies into reducing side effects and preventing drug resistance during treatment of hormone-dependent breast cancer, development of drugs for blood cancers and state-of-the-art diabetes care and research.

Keep reading